Prevalence of COVID-19 fear and its association with quality of life and network structure among Chinese mental health professionals after ending China's dynamic zero-COVID policy: a national survey.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Frontiers Editorial Office Country of Publication: Switzerland NLM ID: 101616579 Publication Model: eCollection Cited Medium: Internet ISSN: 2296-2565 (Electronic) Linking ISSN: 22962565 NLM ISO Abbreviation: Front Public Health Subsets: MEDLINE
    • Publication Information:
      Original Publication: Lausanne : Frontiers Editorial Office
    • Subject Terms:
    • Abstract:
      Background: China recorded a massive COVID-19 pandemic wave after ending its Dynamic Zero-COVID Policy on January 8, 2023. As a result, mental health professionals (MHPs) experienced negative mental health consequences, including an increased level of fear related to COVID-19. This study aimed to explore the prevalence and correlates of COVID-19 fear among MHPs following the end of the Policy, and its association with quality of life (QoL) from a network analysis perspective.
      Methods: A cross-sectional national study was conducted across China. The correlates of COVID-19 fear were examined using both univariate and multivariate analyses. An analysis of covariance (ANCOVA) was conducted to determine the relationship between fear of COVID-19 and QoL. Central symptoms were identified using network analysis through the "Expected Influence" of the network model while specific symptoms directly correlated with QoL were identified through the "flow function."
      Results: A total of 10,647 Chinese MHPs were included. The overall prevalence of COVID-19 fear (FCV-19S total score ≥ 16) was 60.8% (95% CI = 59.9-61.8%). The binary logistic regression analysis found that MHPs with fear of COVID-19 were more likely to be married (OR = 1.198; p  < 0.001) and having COVID-19 infection (OR = 1.235; p  = 0.005) and quarantine experience (OR = 1.189; p  < 0.001). Having better economic status (good vs. poor: OR = 0.479; p  < 0.001; fair vs. poor: OR = 0.646; p  < 0.001) and health status (good vs. poor: OR = 0.410; p  < 0.001; fair vs. poor: OR = 0.617; p  < 0.001) were significantly associated with a lower risk of COVID-19 fear. The ANCOVA showed that MHPs with fear of COVID-19 had lower QoL [ F  = 228.0, p  < 0.001]. "Palpitation when thinking about COVID-19" was the most central symptom in the COVID-19 fear network model, while "Uncomfortable thinking about COVID-19" had the strongest negative association with QoL (average edge weight = -0.048).
      Conclusion: This study found a high prevalence of COVID-19 fear among Chinese MHPs following the end of China's Dynamic Zero-COVID Policy. Developing effective prevention and intervention measures that target the central symptoms as well as symptoms correlated with QoL in our network structure would be important to address COVID-19 fear and improve QoL.
      Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
      (Copyright © 2023 Lam, Chen, Zhang, Sha, An, Su, Cheung, Ungvari, Ng, Xiang and Feng.)
    • References:
      Z Gesundh Wiss. 2021 Oct 09;:1-10. (PMID: 34660175)
      Behav Res Methods. 2018 Feb;50(1):195-212. (PMID: 28342071)
      J Anxiety Disord. 2020 Oct;75:102291. (PMID: 32827869)
      Ann Acad Med Singap. 2020 Jan;49(3):155-160. (PMID: 32200399)
      J Affect Disord. 2023 Mar 1;324:480-488. (PMID: 36584712)
      Asian J Psychiatr. 2020 Jun;51:102147. (PMID: 32473537)
      Health Psychol Behav Med. 2018 Sep 25;6(1):301-328. (PMID: 34040834)
      Psychosom Med. 2021 May 1;83(4):387-396. (PMID: 33818054)
      Int J Ment Health Addict. 2022;20(1):380-386. (PMID: 32837440)
      Psychol Med. 1998 May;28(3):551-8. (PMID: 9626712)
      Crime Sci. 2021;10(1):4. (PMID: 33585156)
      Nurs Open. 2022 Mar;9(2):1147-1154. (PMID: 34881522)
      Death Stud. 2022;46(3):515-523. (PMID: 33641626)
      Health Qual Life Outcomes. 2019 Apr 17;17(1):67. (PMID: 30995918)
      Brain Behav Immun Health. 2020 May;5:100073. (PMID: 32313886)
      Brain Behav Immun Health. 2020 Oct;8:100144. (PMID: 32959031)
      J Nurs Manag. 2021 Apr;29(3):395-403. (PMID: 32985046)
      Front Psychol. 2021 Jun 11;12:661078. (PMID: 34177712)
      Front Psychiatry. 2023 Feb 16;14:1113122. (PMID: 36873201)
      Int J Ment Health Addict. 2022;20(3):1537-1545. (PMID: 32226353)
      Compr Psychiatry. 2020 Nov;103:152198. (PMID: 32980595)
      QJM. 2020 Oct 1;113(10):707-712. (PMID: 32539153)
      J Affect Disord. 2022 Oct 1;314:193-200. (PMID: 35780965)
      Psychiatr Clin North Am. 2012 Mar;35(1):15-36. (PMID: 22370488)
      J Pers Med. 2022 Nov 11;12(11):. (PMID: 36422068)
      Res Dev Disabil. 1995 Jan-Feb;16(1):51-74. (PMID: 7701092)
      Psychol Health Med. 2022 Feb;27(2):444-452. (PMID: 34192997)
      J Clin Psychol. 2022 Feb;78(2):149-166. (PMID: 34240422)
      World Psychiatry. 2017 Feb;16(1):5-13. (PMID: 28127906)
      Int J Ment Health Addict. 2021;19(5):1875-1888. (PMID: 32346359)
      Soc Sci Med (1967). 1977 Jan;11(1):3-10. (PMID: 887955)
      Annu Rev Clin Psychol. 2013;9:91-121. (PMID: 23537483)
      Front Psychol. 2020 Oct 21;11:561536. (PMID: 33192830)
      J Med Virol. 2022 May;94(5):1825-1832. (PMID: 35023191)
      Global Health. 2020 Oct 8;16(1):95. (PMID: 33032629)
      Med Educ Online. 2020 Dec;25(1):1782594. (PMID: 32573367)
      Int J Ment Health Addict. 2023;21(2):976-992. (PMID: 33642957)
      PLoS One. 2022 Jul 27;17(7):e0270567. (PMID: 35895738)
      PLoS One. 2021 Mar 12;16(3):e0247679. (PMID: 33711026)
      Encephale. 2020 Jun;46(3S):S73-S80. (PMID: 32370984)
      Rev Bras Enferm. 2020 Sep 18;73(suppl 2):e20200338. (PMID: 32965402)
      BJPsych Open. 2022 Mar 21;8(2):e73. (PMID: 35307051)
      Psychol Res Behav Manag. 2022 Jul 28;15:1931-1942. (PMID: 35923166)
      Dig Dis Sci. 2010 Mar;55(3):724-32. (PMID: 19255844)
      SN Compr Clin Med. 2020;2(8):1069-1076. (PMID: 32838147)
      J Formos Med Assoc. 2006 Apr;105(4):299-309. (PMID: 16618610)
      J Affect Disord. 2022 Feb 1;298(Pt A):126-133. (PMID: 34715164)
      JMIR Public Health Surveill. 2020 Apr 27;6(2):e18576. (PMID: 32319956)
      J Affect Disord. 2020 Nov 1;276:312-315. (PMID: 32871661)
      Int J Environ Res Public Health. 2020 Apr 19;17(8):. (PMID: 32325888)
      Int J Biol Sci. 2020 Mar 15;16(10):1732-1738. (PMID: 32226291)
      Clin Microbiol Infect. 2009 Aug;15(8):743-7. (PMID: 19754730)
      Int J Ment Health Addict. 2021;19(6):2383-2391. (PMID: 32837422)
      N Engl J Med. 1999 Oct 28;341(18):1329-35. (PMID: 10536124)
      Lancet. 2020 Feb 29;395(10225):676. (PMID: 32113495)
      Perspect Psychol Sci. 2016 Sep;11(5):597-605. (PMID: 27694457)
      Curr Psychol. 2022 Jan 7;:1-10. (PMID: 35018085)
      Behav Res Methods. 2018 Apr;50(2):853-861. (PMID: 28718088)
      Emerg Microbes Infect. 2023 Dec;12(1):2191738. (PMID: 36920784)
      Diabetes Metab Syndr. 2020 Sep - Oct;14(5):779-788. (PMID: 32526627)
      Soc Psychiatry Psychiatr Epidemiol. 2021 Jan;56(1):1-11. (PMID: 33245379)
      Int J Ment Health Addict. 2022;20(5):2813-2822. (PMID: 34539282)
      EClinicalMedicine. 2020 Jun 27;24:100424. (PMID: 32766539)
      Int J Ment Health Addict. 2022;20(2):1273-1288. (PMID: 33456407)
      Nature. 2022 Mar;603(7902):700-705. (PMID: 35104835)
      Front Psychiatry. 2021 Apr 15;12:649989. (PMID: 33935836)
      Front Psychiatry. 2021 Jun 15;12:567381. (PMID: 34211406)
      Am J Infect Control. 2022 Mar;50(3):312-318. (PMID: 34774892)
      Lancet Reg Health West Pac. 2023 Jan 31;30:100702. (PMID: 36741798)
      Int J Environ Res Public Health. 2022 Jun 02;19(11):. (PMID: 35682405)
      Emerg Med Int. 2021 Nov 25;2021:6566981. (PMID: 34868685)
      J Affect Disord. 2022 Aug 15;311:181-188. (PMID: 35594975)
      J Anxiety Disord. 2020 Mar;70:102196. (PMID: 32078967)
      Int J Environ Res Public Health. 2021 Apr 22;18(9):. (PMID: 33922281)
      Lancet Respir Med. 2023 Feb;11(2):132. (PMID: 36535298)
      Cureus. 2020 Aug 14;12(8):e9741. (PMID: 32944456)
      Int J Gen Med. 2021 Dec 06;14:9371-9378. (PMID: 34908866)
      Int J Environ Res Public Health. 2022 Aug 12;19(16):. (PMID: 36011583)
      Ann Intern Med. 1993 Apr 15;118(8):622-9. (PMID: 8452328)
      JAMA Netw Open. 2020 Mar 2;3(3):e203976. (PMID: 32202646)
      Int J Biol Sci. 2022 Aug 21;18(14):5314-5316. (PMID: 36147473)
      Indian J Psychiatry. 2020 Jul-Aug;62(4):363-369. (PMID: 33165355)
      Actas Esp Psiquiatr. 2016 Mar-Apr;44(2):55-63. (PMID: 27099211)
      Cochrane Database Syst Rev. 2020 Jul 5;7:CD012527. (PMID: 32627860)
      BMC Psychiatry. 2016 Apr 05;16:89. (PMID: 27044309)
      BMC Med Res Methodol. 2012 Mar 27;12:37. (PMID: 22452994)
      J Clin Nurs. 2023 Mar 15;:. (PMID: 36919674)
      Ann Med Psychol (Paris). 2021 Jan 6;:. (PMID: 33518767)
      Curr Psychol. 2022 Jan 13;:1-8. (PMID: 35039735)
      J Abnorm Psychol. 2016 Aug;125(6):747-57. (PMID: 27505622)
      J Ment Health. 2021 Feb;30(1):1-2. (PMID: 32339041)
      Cities. 2021 May;112:103138. (PMID: 33564205)
      Front Psychiatry. 2021 Sep 07;12:708430. (PMID: 34557117)
      J Affect Disord. 2016 Jan 1;189:314-20. (PMID: 26458184)
      BMC Health Serv Res. 2021 Sep 6;21(1):923. (PMID: 34488733)
      Int J Ment Health Addict. 2022;20(3):1560-1574. (PMID: 34876889)
      BMC Psychiatry. 2021 May 12;21(1):250. (PMID: 33980215)
      Int J Soc Psychiatry. 2021 Mar;67(2):175-181. (PMID: 32674637)
    • Contributed Indexing:
      Keywords: COVID-19; fear; mental health professionals; network analysis; quality of life
    • Publication Date:
      Date Created: 20231115 Date Completed: 20231116 Latest Revision: 20240429
    • Publication Date:
      20240430
    • Accession Number:
      PMC10642929
    • Accession Number:
      10.3389/fpubh.2023.1280688
    • Accession Number:
      37965522